Products for Research Use Only
RegisterLogin

(E) -Tadehaginoside

CAT: 0804-HY-N15691ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N15691ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(E) -Tadehaginoside is the E-isomer of Tadehaginoside. Tadehaginoside, a phenylpropanoid glycoside, is a regulator of lipogenesis and glucose consumption. Tadehaginoside has antioxygenic property. Tadehaginoside mediates liver protection against oxidative stress injury and inflammation by regulating Nrf2 and NF-κB signaling pathways in hepatocytes. Tadehaginoside can be used for the study of obesity and diabetes[1][2].
CAS Number
283176-41-0
UNSPSC
12352005
Target
Keap1-Nrf2; NF-κB
Related Pathways
NF-κB
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
OC(C=C1)=CC=C1/C=C/C(OC[C@H]([C@H]([C@@H]([C@H]2O)O)O)O[C@H]2OC3=CC(O)=CC(O)=C3)=O
Molecular Formula
C21H22O10
Molecular Weight
434.39
References & Citations
[1]Tang A, et al. Antihepatotoxic effect of tadehaginoside, extracted from Tadehagi triquetrum (L.), against CCl4-lesioned rats through activating the Nrf2 signaling pathway and attenuating the inflammatory response. Inflammation. 2014 Aug;37 (4) :1006-14.|[2]Zhang X, et al. Tadehaginoside modulates lipogenesis and glucose consumption in HepG2 cells. Nat Prod Res. 2015;29 (24) :2287-90.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N15698Tadehaginoside E
HY-N15691Tadehaginoside
HY-128978(E, E) -RAMB4
HY-Y0248-01(E, ​E) ​-​Farnesol
HY-114770(E, E) -GLL398
HY-N0007-01(E, E) -Bisdemethoxycurcumin
HY-W019710-01(E, E) -RGFP966
HY-131520(E, E, E) -Farnesyl alcohol azide
HY-N12873(E, E, E, ) -10,12,14-Hexadecatrienal
HY-Y0248R-01(E, E) -Farnesol (Standard)

Alternative Products

CatalogName
GTR19266303-01Tadehaginoside
GTR19266133-01Tadehaginoside E
TN11463-01(E) -Tadehaginoside

Popular Products